Quarterly report pursuant to Section 13 or 15(d)

Loss per Share (Details)

v3.24.3
Loss per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator (Basic and Diluted):        
Net loss $ (5,385) $ (9,240) $ (20,910) $ (23,802)
Change in value for stock settled consideration 8 11 33 48
Adjusted net loss $ (5,377) $ (9,229) $ (20,877) $ (23,754)
Denominator:        
Weighted average common shares issued and outstanding (in shares) 38,778 38,509 38,645 38,755
Deduct: Unvested RSAs (in shares) (16) (17) (16) (15)
Weighted average common shares outstanding (in shares) 38,762 38,492 38,629 38,740
Basic loss per common share (in dollars per share) $ (0.14) $ (0.24) $ (0.54) $ (0.61)
Weighted average common shares outstanding from above (in shares) 38,762 38,492 38,629 38,740
Add: Dilutive effect of RSUs, RSAs & ESPP (in shares) 0 0 0 0
Add: Contingently issuable shares (in shares) 0 0 0 0
Weighted average common shares outstanding (in shares) 38,762 38,492 38,629 38,740
Diluted loss per common share (in dollars per share) $ (0.14) $ (0.24) $ (0.54) $ (0.61)
Antidilutive shares excluded from diluted loss per common share (in shares) 1,001 1,069 1,116 1,754
Restricted Stock Awards | 2013 Omnibus Equity Incentive Plan        
Denominator:        
Vesting period     1 year